|
XPNPEP3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.4189988314165E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.18687348416825E-12 |
| Normal-vs-Stage2 |
1.761140E-03 |
| Normal-vs-Stage3 |
1.81944999999573E-05 |
| Normal-vs-Stage4 |
2.06140000003074E-06 |
| Stage1-vs-Stage2 |
2.740600E-01 |
| Stage1-vs-Stage3 |
4.332600E-01 |
| Stage1-vs-Stage4 |
7.358600E-01 |
| Stage2-vs-Stage3 |
7.678400E-01 |
| Stage2-vs-Stage4 |
4.094800E-01 |
| Stage3-vs-Stage4 |
4.860000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.84470241701729E-11 |
| Normal-vs-AfricanAmerican |
7.4718000009355E-08 |
| Normal-vs-Asian |
3.769800000053E-06 |
| Caucasian-vs-AfricanAmerican |
4.102000E-01 |
| Caucasian-vs-Asian |
1.959390E-01 |
| AfricanAmerican-vs-Asian |
1.226770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.67359484446206E-12 |
| Normal-vs-Female |
1.25509999948648E-07 |
| Male-vs-Female |
1.413820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.70799999699156E-08 |
| Normal-vs-Extreme_Weight |
1.71396230541632E-12 |
| Normal-vs-Obese |
1.39750000016647E-07 |
| Normal-vs-Extreme_Obese |
1.55961999999121E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.183800E-01 |
| Normal_Weight-vs-Obese |
4.017200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.123200E-01 |
| Extreme_Weight-vs-Obese |
2.850300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.377600E-01 |
| Obese-vs-Extreme_Obese |
5.629200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.398500E-04 |
| Normal-vs-Age(41-60Yrs) |
8.38790004120682E-09 |
| Normal-vs-Age(61-80Yrs) |
2.44839704066635E-11 |
| Normal-vs-Age(81-100Yrs) |
4.03599999976301E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.463000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.071600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.656800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.413570E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.658400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.283800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.73827660335746E-12 |
| Normal-VS-Type2 PRCC |
1.8509999977212E-08 |
| Normal-VS-KIRP CIMP |
3.441800E-02 |
| Normal-VS-Unclassified PRCC |
1.63349999970919E-07 |
| Type1 PRCC-VS-Type2 PRCC |
4.468200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.607800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.416200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.745000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.897800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.469200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.02740002563928E-09 |
| Normal-vs-N1 |
2.007500E-04 |
| Normal-vs-N2 |
8.048400E-04 |
| N0-vs-N1 |
4.458200E-01 |
| N0-vs-N2 |
8.189600E-01 |
| N1-vs-N2 |
5.831200E-01 |
|
|
